Simpson-Golabi-Behmel syndrome (SGBS) is an X-linked condition charact
erized by pre- and postnatal overgrowth with visceral and skeletal ano
malies, To identify the causative gene, breakpoints in two female pati
ents with X;autosome translocations were identified. The breakpoints o
ccur near the 5' and 3' ends of a gene, GPC3, that spans more than 500
kilobases in Xq26; in three families, different microdeletions encomp
assing exons cosegregate with SGBS. GPC3 encodes a putative extracellu
lar proteoglycan, glypican 3, that is inferred to play an important ro
le in growth control in embryonic mesodermal tissues in which it is se
lectively expressed. Initial western- and ligand-blotting experiments
suggest that glypican 3 forms a complex with insulin-like growth facto
r 2 (IGF2), and might thereby modulate IGF2 action.